Aethlon Medical Inks Collaboration Agreement With 34 Lives To Evaluate Ability Of Hemopurifier; Financial Terms Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Aethlon Medical has entered into a collaboration agreement with 34 Lives to evaluate the ability of Hemopurifier. The financial terms of the agreement were not disclosed.
July 24, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aethlon Medical's collaboration with 34 Lives to evaluate Hemopurifier could potentially enhance the company's product portfolio and market position.
The collaboration agreement between Aethlon Medical and 34 Lives to evaluate Hemopurifier could potentially enhance Aethlon's product portfolio and strengthen its market position. However, the financial terms of the agreement were not disclosed, which may cause some uncertainty among investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100